You have 5 free articles left this month. Get your free Basic subscription now and gain instant access to more.

Three Bulgarian companies sign drug supply deals worth total 3.8 mln euro with oncology hospital

Author Vasil Kolchev
Three Bulgarian companies sign drug supply deals worth total 3.8 mln euro with oncology hospital Author: Brice Ambrosiak. Licence: Creative Commons

SOFIA (Bulgaria), October 14 (SeeNews) - The National Oncology Hospital in Sofia awarded local companies Danhson Trading, Sopharma Trading and Phoenix Pharma deals for supply of pharmaceuticals for the needs of the hospital worth a total 7.4 million levs ($4.4 million/3.8 million euro), the contracting authority said on Wednesday.

The Phoenix Pharma contract amounts to 7.2 million levs, while the deals with Sopharma Trading and Danhson Trading are worth 211,640 levs and 4,240 levs, respectively, the hospital said in a notice to the public procurement agency.

The contracts envisages the delivery of drugs affecting blood and hematopoietic organs, anti-tumor and immunomodulatory drugs, as well as other drugs, over a one-year period, the notice added.

The deal with Phoenix Pharma was signed on September 28, while the other two deals were signed on October 7.

Phoenix Pharma is a unit of German healthcare provider Phoenix Group, active in 27 countries across Europe.

Sofia-based Sopharma Trading is a unit of Bulgarian drug maker Sopharma.

The core business of Radomir-based Dahnson, founded in 2015, is development, production and marketing of pharmaceutical products, food supplements and cosmetics.

(1 euro = 1.95583 levs)

Compare